Clinical characteristics and risk factors forPneumocystis jiroveciipneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case–control study of 17 patients

2013 ◽  
Vol 23 (6) ◽  
pp. 1085-1093 ◽  
Author(s):  
Kaori Watanabe ◽  
Ryoko Sakai ◽  
Ryuji Koike ◽  
Fumikazu Sakai ◽  
Haruhito Sugiyama ◽  
...  
2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 973-973
Author(s):  
R. Gonzalez Mazario ◽  
J. J. Fragio-Gil ◽  
P. Martinez Calabuig ◽  
E. Grau García ◽  
M. De la Rubia Navarro ◽  
...  

Background:Cardiovascular disease (CV) is the most frequent cause of death in rheumatoid arthritis (RA) patients. It is well known that RA acts as an independent cardiovascular risk factor.Objectives:To assess the CV risk in RA patients using carotid ultrasonography (US) additionally to the traditional CV risk factors.Methods:A prospective transversal case control study was performed, including adult RA patients who fulfilled ACR/EULAR 2010 criteria and healthy controls matched according to CV risk factors. Population over 75 years old, patients with established CV disease and/or chronic kidney failure (from III stage) were excluded. The US evaluator was blinded to the case/control condition and evaluated the presence of plaques and the intima-media thickness. Statistical analysis was performed with R (3.6.1 version) and included a multivariate variance analysis (MANOVA) and a negative binomial regression adjusted by confounding factors (age, sex and CV risk factors).Results:A total of 200 cases and 111 healthy controls were included in the study. Demographical, clinical and US data are exposed in table 1. Not any difference was detected in terms of CV risk factors between the cases and controls. In both groups a relationship between age, BMI and high blood pressure was detected (p<0.001).Table 1.Table 2.RA basal characteristicsDisease duration (years)16,98 (11,38)Erosions (X-Ray of hands/feet)163 (81,5%)Seropositive (RF/anti-CCP)146 (73%)Extra-articular symptoms44 (22%)Intersticial difusse lung disease10 (5%)Rheumatoid nodules14 (7%)Prednisone use103 (51,5%)Median dose of Prednisone last year (mg)2,34 (2,84)sDMARDsMethotrexate104 (52%)Leflunomide29 (14,5%)Hydroxycloroquine9 (4,5%)bDMARDs89 (44,5%) TNFi41 (20,5%) Abatacept15 (7,5%) IL6i22 (11%) RTX11 (5,5%)JAKi26 (13%) Baricitinib11 (5,5%) Tofacitinib15 (7,5%)DAS 28-ESR3,1 (2,3, 3,9)SDAI7,85 (4,04, 13,41)HAQ0,88 (0,22, 1,5)RF (U/mL)51 (15, 164,25)Anti-CCP (U/mL)173 (22, 340)Patients showed higher intima-media (both right and left) thickness compared to controls (p<0.006). Moreover it was also related to the disease duration and DAS28 score (p<0.001). A higher plaque account was noted in cases(p<0.004) and it was also related to the disease duration (p<0.001).Conclusion:RA implies a higher CV risk. Traditional CV risk factors explains only partially the global risk. These findings support that RA acts as an independent cardiovascular risk factor.Disclosure of Interests:None declared


2016 ◽  
Vol 18 (12) ◽  
Author(s):  
Neda Ghamarzad Shishavan ◽  
Saeed Pirouzpanah ◽  
Mehrzad Hajialilo ◽  
Alireza Khabbazi ◽  
Farnaz Jafarpour ◽  
...  

2009 ◽  
Vol 61 (3) ◽  
pp. 305-312 ◽  
Author(s):  
Yukiko Komano ◽  
Masayoshi Harigai ◽  
Ryuji Koike ◽  
Haruhito Sugiyama ◽  
Jun Ogawa ◽  
...  

Rheumatology ◽  
2017 ◽  
Vol 56 (8) ◽  
pp. 1282-1292 ◽  
Author(s):  
Matthew Traylor ◽  
Charles Curtis ◽  
Hamel Patel ◽  
Gerome Breen ◽  
Sang Hyuck Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document